VaramirStart free · no cardSign in
CLDX as of Oct 31 · 13:14 ET
CLDXNasdaqIn Vitro & In Vivo Diagnostic Substances

Celldex Therapeutics, Inc. · Brief

Next report

9 days

Nov 9 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±12.0%
avg realized
±3.1%
Nov 6 '24±11.8%▼−4.20%×0.36
Feb 27 '25±11.4%▲+1.28%×0.11
May 8 '25±10.9%▼−6.10%×0.56
Aug 7 '25±13.8%▼−2.59%×0.19
Q3 FY25±17.3%▲+7.50%×0.43
Q1 FY26±13.6%▼−0.58%×0.04
May 7 '26±7.6%▲+1.95%×0.26
Q2 FY26±9.8%▲+0.36%×0.04
quarterimplied−20%0+20%realized×
Q2 FY26±9.8%▲+0.36%×0.04
May '26±7.6%▲+1.95%×0.26
Q1 FY26±13.6%▼−0.58%×0.04
Q3 FY25±17.3%▲+7.50%×0.43
Aug '25±13.8%▼−2.59%×0.19
May '25±10.9%▼−6.10%×0.56
2 older reports
Feb '25±11.4%▲+1.28%×0.11
Nov '24±11.8%▼−4.20%×0.36
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2

255managers reporting a position in the latest quarterly filings13F · Jun 30 '26
+28.48%change in shares held by the ten largest reporting managers13F · Jun 30 '26

Bear2 of 4

8 of 8recent reports where the move came in under the options implied rangeEarnings history
8 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

CLDX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 26impliedImplied move: ±11.4% into Nov 9 earnings (Oct 26 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.